Berkeley Haas Case Series
The Berkeley Haas Case Series is a collection of business case studies created by UC Berkeley faculty
by Kristiana Raube
The Napo Pharmaceuticals case study provides students with an example of a biotech company that has pursued a triple bottom line of people, planet, and profit while making life-saving drugs like crofelemer to deal with diarrhea in adult HIV/AIDS patients and potentially diarrhea for children and other neglected diseases around the world. The case study focuses on CEO and founder, Lisa Conte's challenging road to the point where she and her distribution partners achieved FDA approval for the drug. The case study outlines the issues such mission-oriented biotech companies faced in the more typical profit-oriented world of biotech. Please note: this case also has a supplementary case available. The (B) supplement can be found using product number B5785.
Pub Date: Feb 13, 2014
Discipline: General Management
Subjects: Corporate social entrepreneurship, Health care, Strategic philanthropy, Nonprofit organizations, Entrepreneurship, Venture capital, CEO, Social issues, Society and business relations, Women in business, Partnerships, R&D, Social responsibility
Product #: B5784-PDF-ENG
Industry: Biotechnology
Geography: United States, California, Asia, India
Length: 15 page(s)
